DelMar raises $10M in registered direct offering

Cancer company DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) said on Sept. 22 it closed a registered direct offering, raising $10 million through the sale of 8 million shares at $1.25. Investors also rece...